Indigo Paints Ltd

Q2 FY23 Earnings Call Analysis

Consumer Durables

Full Stock Analysis
fundraise: No informationcapex: Yesrevenue: Category 2margin: Category 3orderbook: Yes
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- Trial production has been successfully carried out at a new water-based plant in Tamil Nadu; commercial production is expected to commence in the next couple of weeks pending final statutory approvals. - Construction has started on a new water-based plant in Jodhpur with a capacity of 90,000 KL per annum, expected to be operational by the end of FY2025. - A solvent-based paint plant with a capacity of 12,000 KL per annum is also planned at Jodhpur, expected to be operational in the next fiscal year. - The company has acquired a 51% stake in Apple Chemie India Pvt Ltd, looking for organic growth and possibly acquiring similar companies if synergistic opportunities arise. - Apple Chemie is expanding its sales and marketing footprint across multiple states to grow its B2B segment significantly over the next few years.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- Indigo Paints expects continued strong growth momentum, having achieved more than 3x the industry growth on a standalone basis and about 4x on a consolidated basis recently. - The company aims to sustain superior growth for several successive quarters to instill confidence in shareholders. - Focus on Tier-1 and Tier-2 towns is expected to increase their contribution to revenue, potentially reaching 38-40% by the end of the year. - Growth in Kerala, previously contributing about 33%, is expected to decline gradually to around 25% over the next 1-2 years, reducing dependence on this single region. - Expansion in Apple Chemie’s B2B segment could see top-line growth toward ₹200 Crores in 2-3 years. - Network expansion will continue with a strategic increase in throughput per dealer rather than rapid dealer count growth. - Advertising spends will rise slower than topline growth, improving EBITDA margins and supporting profitable growth.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- Indigo Paints expects to maintain high growth momentum with Q2 starting on a very positive note, continuing the strong performance of Q1. - They aim to sustain growth at 2x to 3x the industry rate, building on a history of 10 years of outperforming the industry before a taper in FY2022. - Growth focus is on profitable expansion, with consistent improvement in EBITDA and PAT margins (Q1 EBITDA up 35.3%, PAT up 57.15% YoY). - Apple Chemie, acquired recently, is expected to grow from ₹42 Crores to about ₹200 Crores top-line in "a couple of years" with stable margin contribution. - EBITDA and gross margins are expected to remain strong, as Apple Chemie’s margins are similar to Indigo’s current margins. - Geographic diversification is expected to reduce dependency on Kerala (from ~33% now to ~25% in next 1-2 years), enhancing overall growth prospects. - Advertising spends will grow slower than topline, improving EBITDA margins further.
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- Apple Chemie, a subsidiary of Indigo Paints, currently has an order book indicating potential for 40% or more growth within its existing geography, primarily Maharashtra. - The company is expanding Apple Chemie’s sales and marketing teams across 8-9 other states, aiming to generate reasonable order flows from these new regions starting in Q2. - Momentum for order inflows is expected to increase significantly in the second half of the year. - Apple Chemie operates in the B2B institutional segment focusing on high-pedigree customers like L&T, Shapoorji Pallonji, B. G. Shirke, and Afcons. - The expansion signals confidence in scaling the order book beyond the current footprint, potentially growing revenue to around INR 200 Crores within a few years.
💰

fundraise

Any current/future new fundraising through debt or equity?

- The transcript does not mention any current or planned fundraising through debt or equity. - There is no discussion of raising capital or issuing shares in the provided Q&A or management comments. - The focus appears to be on internal growth initiatives, operational expansion, and strategic acquisitions (e.g., Apple Chemie). - Management emphasizes profitable growth and organic expansion rather than external fundraising. - No indication of plans for equity or debt issuance in near term is disclosed.